rare cases of HIV-positive body cavity-based lymphoma and with multicentric Castleman disease Background. Kaposi sarcoma ( KS) may arise as a complication of kidney transplantation. In the Saint [1] [2] [3] [4] . The distribution of the virus in the population Luc Teaching Hospital in Brussels, patients of both conforms to the pattern expected for a sexually transBelgian and foreign origin are treated. The prevalence mitted disease and its prevalence corresponds to the of human herpes virus 8 (HHV-8) infection differs in risk for KS [5][6][7]. Some studies suggest that nondifferent geographical settings. We wanted to estimate sexual modes of transmission may be important in the background infection rate and the risk of infection highly endemic countries [8]. Before confirmation of in our transplant population: a first step towards the aetiologic agent it had already been supposed on evaluating the necessity of HHV-8 screening.
Introduction
Sera (210) from potential donors were tested over a period of 7 years from 1992 to 1998 (30 successive sera each year).
Human herpes virus 8 (HHV-8) has been associated
All of these donors died in Belgium and were mostly of with different forms of Kaposi sarcoma ( KS), with Belgian origin. Samples had been stored at −20°C for up to J. Sheldon et al. 1444 cases were available. A group of 198 renal transplant recipi-group M, the others from group B. At present, each ents was also tested serologically. For all patients at least of the four seroconverters have a good functioning two serum samples were available, one pre-transplant and kidney and none has developed KS after 3-7 years. one taken between 6 months and 1 year post-transplantation. For the purpose of the study, the recipient population was arbitrarily divided into two subgroups according to their origin at the time of transplantation: group B comprised143 Discussion patients who had local residency at the time of transplantation; group M comprised 55 recipients who originated from a foreign state inside the European Community, mostly from KS is a relatively rare disease in our patient population.
Mediterranean countries.
Between June 1963 and May 1999, 2807 renal transSera were tested for the presence of antibodies to HHV-8 plantations were performed at our institution; only in a dilution of 1:100 by an enzyme-linked immunosorbant eight KS cases (0.3%) have been documented, which assay (ELISA) using two HHV-8 antigens and a control indicates that the risk is very low. Since the discovery antigen. The two HHV-8 antigens were a recombinant frag-of HHV-8 several serological assays have been ment [7, 19] . In addition, sera were tested by immunofluorescence cases were negative. A low prevalence of HHV-8 in a dilution of 1:50 for the presence of antibodies to the antibodies (3.3%) was found among donors in our 'latency-associated nuclear antigen', as described previously hospital. Only one positive donor gave a kidney and a [7] . Sera that were positive by ELISA, but negative by liver to local recipients in 1993 (not in this study). infection is not an inescapable result of transplantation from a positive donor.
Pre-transplant prevalence of HHV-8 antibodies
Results
among graft recipients was 7.6%. Geographically, a gradient of prevalence can be seen between highly endemic areas like central Africa and areas of low In the donor group 7/210 were HHV-8 positive (3.3%). The four cases of post-transplant KS were seropositive endemicity such as northern Europe or the US [10,11].
Our findings confirmed this as 14.8% of recipients from and the four lymphoma cases were negative. Of 198 pre-transplant sera, 15 were positive (7.6%). Among group M were antibody-positive as compared with only 4.9% in group B. The prevalence is, however, not these 15 positive cases, more group M patients (14.8% positive) were affected than others (4.9%); this differ-only defined geographically because within a given geographical area wide variations may exist between ence is significant (P=0.02). Results by gender are given in Table 1 . Ten of 77 (12.9%) females were population groups. The higher prevalence in women (12.9%) than in men (4%) is curious but may be due positive (six from the M group, four from the B group) and 5/123 (4%) men were positive (two from the M to the small group of positive individuals. In other studies the rates of HHV-8 infection between men and group, three from the B group). The difference of prevalence between sexes is significant (P=0.03), but women are generally similar, but KS is seen mainly in men. This suggests that risk factors other than HHV-8 is largely due to the M group. Six months to 1 year post-transplantation, 18/198 (9%) were positive: four are involved. The higher prevalence in women, if real, might be explained by a more efficient sexual transmishad documented seroconversion and one positive individual became negative. One seroconverter was from sion from men to women than vice versa, or by a was much higher than the 2.1% found in our study. 
